State Street Corp Increases Stake in 908 Devices Inc. (NASDAQ:MASS)

State Street Corp grew its position in 908 Devices Inc. (NASDAQ:MASS) by 1.2% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 479,044 shares of the company’s stock after buying an additional 5,704 shares during the period. State Street Corp owned approximately 1.38% of 908 Devices worth $1,662,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. SG Americas Securities LLC bought a new stake in shares of 908 Devices during the third quarter valued at approximately $36,000. Drive Wealth Management LLC bought a new stake in shares of 908 Devices in the 3rd quarter worth $50,000. Townsquare Capital LLC purchased a new position in shares of 908 Devices in the third quarter worth $50,000. 49 Wealth Management LLC lifted its holdings in shares of 908 Devices by 16.2% during the third quarter. 49 Wealth Management LLC now owns 31,099 shares of the company’s stock valued at $108,000 after purchasing an additional 4,343 shares in the last quarter. Finally, American Century Companies Inc. boosted its position in shares of 908 Devices by 18.6% during the second quarter. American Century Companies Inc. now owns 33,718 shares of the company’s stock valued at $174,000 after buying an additional 5,295 shares during the last quarter. Institutional investors own 88.06% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have weighed in on the company. Leerink Partners reissued a “market perform” rating and issued a $4.00 target price (down previously from $12.00) on shares of 908 Devices in a research report on Wednesday, November 13th. Stifel Nicolaus lowered their price objective on shares of 908 Devices from $17.00 to $6.00 and set a “buy” rating on the stock in a research report on Wednesday, November 13th. Finally, Leerink Partnrs cut shares of 908 Devices from a “strong-buy” rating to a “hold” rating in a report on Wednesday, November 13th.

908 Devices Stock Up 3.3 %

NASDAQ MASS opened at $2.20 on Thursday. The company has a 50-day moving average price of $2.65 and a 200-day moving average price of $3.76. 908 Devices Inc. has a 52 week low of $1.81 and a 52 week high of $11.16. The firm has a market capitalization of $76.61 million, a P/E ratio of -1.24 and a beta of 0.92.

908 Devices Company Profile

908 Devices Inc, a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling.